Other studies have shown that plasma VEGF-A levels and VEGFR-1 and VEGFR-2 proteins were higher in AML than in ALL and that VEGFR-1, although expressed also in ALL, was the receptor subtype most abundantly expressed in chronic and acute leukemia of myeloid origin [280,281]. The gene discussed is VEGFA; the disease is acute leukemia.